Bristol Myers Squibb to acquire RayzeBio for USD 4.1 billion
Bristol Myers Squibb announced plans to acquire RayzeBio for USD 4.1 billion.…
Unveiling the Future of Radiology: Key Trends from RSNA 2023
The RSNA 109th Scientific Assembly and Annual Meeting in Chicago focused on…
PIRA in Children With MS: Early Disease-Modifying Therapy May Offer Protection
A study published in JAMA Neurology found that children with Multiple Sclerosis…
Digital health leaders on the most noteworthy events of 2023
Executives in the digital health space shared the most significant events in…
Seven updates on ultraprocessed foods
Healio's coverage of research on ultraprocessed foods covers the significant impact these…
Federal court suspends ITC’s import ban on Apple Watches
Apple Watches were facing a sales ban due to a feature similar…
Going for a walk wasn’t really a thing 300 years ago—the Victorians turned it into a popular pastime
Walking wasn't a popular pastime until the late 1700s. The term "pedestrianism"…
Your unique microbiome may be used to improve and personalize your future medical experience
Researchers discuss using the gut microbiome in personalized medicine. Personalized medicine based…
What to Expect Over the Long Term
Ulcerative colitis (UC) is a long-term illness characterized by unpredictable symptoms that…
FDA Expands Label for CVRx Barostim System in HF
The FDA has approved an expanded label for the Barostim neuromodulation system…